Companion Animal Welfare

Immune Thrombocytopenia in Dogs — Emergency Welfare Management

Immune thrombocytopenia (ITP) is a life-threatening autoimmune destruction of platelets causing spontaneous bleeding, requiring emergency intervention and sustained immunosuppression with significant welfare implications throughout treatment.

Key Facts

Welfare Considerations

Immune thrombocytopenia creates acute welfare crises that may develop without warning. A dog with a platelet count of 5,000/uL can develop life-threatening haemorrhage from minor trauma or even spontaneously. Internal bleeding — into body cavities or the brain — can cause rapid deterioration and death. The visual signs of severe thrombocytopenia are dramatic: sheets of petechiae covering mucous membranes and skin, nosebleeds that are difficult to control, and blood in every body fluid. Treatment requires careful management of activity levels — cage rest is recommended to prevent trauma-induced haemorrhage while immunosuppression takes effect. High-dose corticosteroid side effects (polydipsia, polyuria, panting, behavioural changes) are significant during the acute phase. Monitoring platelet counts every 3-5 days tracks response and guides dose reduction. The relapse rate means that even successfully treated dogs face the possibility of a second crisis, and owners should be educated about early signs and the importance of prompt rechecking. Quality-of-life monitoring using behavioural indicators alongside haematological parameters provides a more complete welfare picture than blood counts alone.

What You Can Do